Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Bone diseases

Epidemiology

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

19-11-2018 | Osteoporosis | Article

Risk of subsequent fracture after prior fracture among older women

Balasubramanian A et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4732-1

23-07-2018 | Osteoporosis | Article

Incidence, risk factors, and fracture healing of atypical femoral fractures: A multicenter case-control study

Lim SJ et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4640-4

20-07-2018 | Osteoporosis | Article

Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older

van der Velde RY et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4636-0

21-06-2018 | Osteoporosis | Article

Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys

Yoshimura N et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4596-4

22-05-2018 | Osteoporosis | Article

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride

Antoniou T et al. BMC Musculoskelet Disord 2018; 19: 160. doi: 10.1186/s12891-018-2076-9

17-05-2018 | Osteoporosis | Article

Anti-osteoporosis drug use: Too little, too much, or just right? The HUNT study, Norway

Hoff M et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4560-3

14-05-2018 | Osteoporosis | Article

Prevalence and comorbidity of osteoporosis: A cross-sectional analysis on 10,660 adults aged 50 years and older in Germany

Puth MT et al. BMC Musculoskelet Disord 2018; 19: 144. doi: 10.1186/s12891-018-2060-4

02-05-2018 | Osteoporosis | Review | Article

Novel imaging modalities in osteoporosis diagnosis and risk stratification

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

Gout as a risk factor for osteoporosis: Epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals

This first population-based epidemiologic study supports the hypothesis that compared with individuals without gout; those with gout have a modest increase in the risk of developing osteoporosis in future [read more].
Kok VC et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4375-2

Gout as a risk factor for osteoporosis: Epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals

18-03-2017 | Osteoporosis | Article

Trends in osteoporosis and low bone mass in older US adults, 2005–2006 through 2013–2014

This research article determined evidence of decline in femur neck bone mineral density (BMD) but not in lumbar spine BDM between 2005–2006 and 2013–2014 in the US population.

Looker AC et al. Osteoporos Int 2017. doi:10.1007/s00198-017-3996-1

18-03-2017 | Osteoporosis | Review | Article

The epigenome at the crossroad between social factors, inflammation, and osteoporosis risk

The authors explore the hypothesis that early life experiences may induce stress reactions and other responses that modify DNA methylation patterns and consequently influence the risk of osteoporosis in later life.

Riancho JA, Brennan-Olsen SL. Clinic Rev Bone Miner Metab 2017;15:59-68. doi:10.1007/s12018-017-9229-5

More


More on bone diseases


« Back to main page | Osteoporosis | Clinical trials | Diagnosis and screening | Epidemiology | Fracture | Lifestyle interventions | Medications | Pain | Pathophysiology | Prevention | Quality of life | Risk prediction


Image Credits